Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001562180-25-004834

EVP & GENERAL COUNSEL sold 11,000 shares at an average $279.96 ($3,079,514)

  • EVP & GENERAL COUNSEL acquired 11,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

MAHON PAUL A · EVP & GENERAL COUNSEL

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2025-06-12 Exercise or conversion : show line 1 in the form 10b5-1 +11,000 $135.42 $1,489,620 47,781 D
2025-06-12 Sale : show line 2 in the form 10b5-1 −506 $275.98 $139,647 47,275 D
2025-06-12 Sale : show line 3 in the form 10b5-1 −1,100 $276.95 $304,648 46,175 D
2025-06-12 Sale : show line 4 in the form 10b5-1 −1,837 $278.41 $511,441 44,338 D
2025-06-12 Sale : show line 5 in the form 10b5-1 −1,425 $279.51 $398,303 42,913 D
2025-06-12 Sale : show line 6 in the form 10b5-1 −1,375 $280.70 $385,957 41,538 D
2025-06-12 Sale : show line 7 in the form 10b5-1 −4,557 $281.56 $1,283,063 36,981 D
2025-06-12 Sale : show line 8 in the form 10b5-1 −200 $282.27 $56,454 36,781 D
Open-market sales · 11,000 sh · avg $279.96 · $3,079,514

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2025-06-12 Exercise or conversion : show line 9 in the form 10b5-1 Stock Option −11,000 $135.42 2027-03-15 11,000 132,000 D
Loading xslF345X05/primarydocument.xml…